← All trials
NCT05629624
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 7, 2022
- Primary completion
- Aug 31, 2024
- Completion date
- Aug 31, 2024
- First posted
- Nov 29, 2022
- Last posted
- Nov 29, 2022
- Enrollment
- 280
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Harvard UniversityLead sponsor
- Harvard UniversityReponsible party - principal investigator
- International Center for Diarrheal Disease ResearchCollaborator
- University of The West IndiesCollaborator
- University of AucklandCollaborator
- University of The West IndiesOverall official - principal investigator
- Wellcome TrustCollaborator
- Harvard UniversityOfficial
- Harvard UniversitySponsor investigator
- University of The West IndiesOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.